Clinical Outcome of Everolimus Treatment of Advanced Neuroendocrine Neoplasms: “Real-life” Data from the German NET-Register

#1200

Introduction: Everolimus (EVE) has importantly impacted the treatment (Tx) of mostly pancreatic NEN.

Aim(s): This study analyzed recent results of routine EVE-Tx from 5 centres of the German NET-Register.

Materials and methods: Multicentric, retrospective analysis of pts. with histologically proven NEN progressive prior to Tx initiation with EVE (initial diagnosis 1988-2013); statistical analysis used SPSS 19.0.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Pape U

Authors: Pape U, Bacher M, Fottner C, Lahner H, Begum N,

Keywords: everolimus, outcome,